Stratos Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5M | Buy |
26,910
+1,465
| +6% | +$272K | 0.23% | 85 |
|
|
2025
Q1 | $5.33M | Buy |
25,445
+12,934
| +103% | +$2.71M | 0.28% | 76 |
|
|
2024
Q4 | $2.22M | Buy |
12,511
+439
| +4% | +$78K | 0.13% | 97 |
|
|
2024
Q3 | $2.38M | Buy |
12,072
+35
| +0.3% | +$6.91K | 0.17% | 94 |
|
|
2024
Q2 | $2.06M | Buy |
12,037
+1,038
| +9% | +$178K | 0.17% | 99 |
|
|
2024
Q1 | $2M | Sell |
10,999
-2,285
| -17% | -$416K | 0.2% | 91 |
|
|
2023
Q4 | $2.06M | Sell |
13,284
-261
| -2% | -$40.5K | 0.24% | 84 |
|
|
2023
Q3 | $2.02M | Buy |
13,545
+966
| +8% | +$144K | 0.3% | 73 |
|
|
2023
Q2 | $1.69M | Buy |
12,579
+1,019
| +9% | +$137K | 0.26% | 78 |
|
|
2023
Q1 | $1.84M | Sell |
11,560
-66
| -0.6% | -$10.5K | 0.31% | 69 |
|
|
2022
Q4 | $1.88M | Sell |
11,626
-141
| -1% | -$22.8K | 0.34% | 71 |
|
|
2022
Q3 | $1.58M | Sell |
11,767
-1,298
| -10% | -$174K | 0.32% | 73 |
|
|
2022
Q2 | $2M | Sell |
13,065
-92
| -0.7% | -$14.1K | 0.38% | 66 |
|
|
2022
Q1 | $2.13M | Buy |
13,157
+556
| +4% | +$90.1K | 0.35% | 68 |
|
|
2021
Q4 | $1.71M | Buy |
12,601
+1,653
| +15% | +$224K | 0.27% | 81 |
|
|
2021
Q3 | $1.18M | Buy |
10,948
+2,491
| +29% | +$269K | 0.21% | 94 |
|
|
2021
Q2 | $953K | Buy |
8,457
+1,064
| +14% | +$120K | 0.26% | 74 |
|
|
2021
Q1 | $800K | Sell |
7,393
-2,492
| -25% | -$270K | 0.25% | 76 |
|
|
2020
Q4 | $1.06M | Buy |
9,885
+1,287
| +15% | +$138K | 0.33% | 73 |
|
|
2020
Q3 | $753K | Buy |
8,598
+2,103
| +32% | +$184K | 0.27% | 76 |
|
|
2020
Q2 | $638K | Buy |
6,495
+2,010
| +45% | +$197K | 0.27% | 76 |
|
|
2020
Q1 | $342K | Buy |
+4,485
| New | +$342K | 0.18% | 81 |
|